Covid, Health
Digest more
FDA Commissioner Dr. Marty Makary and vaccine chief Dr. Vinay Prasad set stricter approval standards for booster shots
The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of serious illness
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit future shots to older Americans and people at higher risk of serious Covid-19 infection.
The rollout of updated COVID vaccines for healthy children and adults is likely to be delayed after the Food and Drug Administration suggested that it will require another clinical trial
Høeg has been skeptical of the safety and value of some vaccines and mandates, raising questions about her approach at the FDA.
The restrictions on Novavax's vaccine could portend changes at the FDA. Commissioner Marty Makary suggested last week that the agency could update its vaccine approval guidelines “in the coming days.”
We want to see vaccines that are available for high-risk individuals, and at the same time, we want some good science,’ FDA Commissioner Marty Makary said.